A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
Active, not recruiting · Phase 3 · NCT03671148
Conditions: Psoriatic Arthritis (PsA)
At a glance
- Research payments reported, 2025
- $519,941
- U.S. investigators named
- 28
- Sites paid
- 29
- Planned or actual enrollment
- 444
About the trial
- Sponsor
- AbbVie
- Tested
- Placebo (biological), Risankizumab (biological)
- Dates
- Started 2019-03-07; completion 2029-01
- Results posted
- Yes
The purpose of this study is to evaluate the safety and efficacy of risankizumab in adults with moderately to severely active psoriatic arthritis (PsA).
From ClinicalTrials.gov, last updated 2026-10-28. Full record, eligibility and contacts (opens in a new tab)
Industry funding
AbbVie Inc. reported $519,941 in research payments for this study in 2025 (221 payments).
Products named: Skyrizi
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Suneet Grewal, M.D. Rheumatology · West Hollywood, CA
- Gerald Y. Ho, M.D. Rheumatology · La Palma, CA
- Christine T. Thai, M.D. Rheumatology · Huntington Beach, CA
- Christopher R. Antolini, MD Rheumatology · Denver, CO
- Julio Gonzalez-paoli, MD Rheumatology · Tampa, FL
- Elias Halpert, MD Rheumatology · Tamarac, FL
- Michael D. Kohen, M.D. Allergy & Immunology · Daytona Beach, FL
- Loutfi Succari, M.D. Rheumatology · Tampa, FL
- Robert A. Hozman, M.D. Rheumatology · Skokie, IL
- Timothy M. Lenardo, M.D. Rheumatology · Springfield, IL
- Jyothi R. Mallepalli, MD Rheumatology · Monroe, LA
- Charles A. Birbara, M.D. Specialist · Worcester, MA
- Steven J. Klein, MD Rheumatology · Hagerstown, MD
- Roger J. Diegel, MD Rheumatology · Kalispell, MT
- William F. Rigby, M.D. Rheumatology · Lebanon, NH
- Adrienne R. Hollander, M.D. Rheumatology · Voorhees, NJ
- Isam Diab, MD Rheumatology · Middleburg Hts, OH
- Alan Kivitz, MD Rheumatology · Duncansville, PA
- Karina Vila-rivera, M.D. Rheumatology · San Juan, PR
- Jacob Aelion, M.D. Specialist · Jackson, TN
- Dhiman Basu, MD Rheumatology · Colleyville, TX
- Paul K. Pickrell, MD Rheumatology · Austin, TX
- Qaiser Rehman, MD Rheumatology · Houston, TX
- Jitendra I. Vasandani, MD Rheumatology · Lubbock, TX
- Fehmida Zahabi, MD Rheumatology · Plano, TX
- Eric C. Mueller, M.D. Rheumatology · Spokane, WA
- Kurt R. Oelke, M.D. Rheumatology · Glendale, WI
- Wassim S. Saikali, MD Rheumatology · Beckley, WV
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Dartmouth Hitchcock Health $42,651
- Tekton Research LLC $39,945
- Rheumatology and Pulmonary Clinic $34,545
- Springfield Clinic LLP $32,465
- Trinity Universal Research Associat $31,186
- Clin Investigation Specialists Inc $31,111
- Paramount Medical Research $30,953
- Altoona Center for Clinical Researc $30,722
- Gcm Medical Group Psc $29,307
- Jitendra Vasandani-Md PA $29,285
- Clinical Pharmacology Study Group $21,665
- West Tennessee Research Institute $20,059
- St Josephs Hospital, FL $19,972
- Precision Comprehensive Clinical $19,967
- Arthritis Northwest PLLC $16,734
- Rheumatic Disease $10,501
- Klein and Associates MD PA $10,058
- University of South Florida $9,002
- East Bay Rheumatology $8,022
- Trabecular Medical Group LLC $7,851
- The Arthritis and Diabetes Clinic I $7,270
- Logan Health Medical Center, MT $7,146
- Advanced Medical Research LLC $6,827
- Denver Arthritis Clinic PC $6,596
- West Broward Rheumatology Associate $5,973
- Millennium Research LLC $4,695
- Dynamed Clinical Research LP $3,945
- Hmd Research LLC $1,365
- Care Access Research LLC $123
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.